Streetbeat News

Analyst Ratings

GRCL

HC Wainwright & Co. analyst Emily Bodnar maintains a 'Buy' rating on Gracell Biotechnologies (NASDAQ:GRCL) and raises the price target from $12 to $13.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 4:18 pm

CSCO

A significant investor has taken a bullish stance on Cisco Systems (NASDAQ:CSCO), with 72% of investors opening trades with bullish expectations and 27% with bearish. The whales have been targeting a price range from $47.5 to $62.5 for Cisco Systems over the last 3 months. The price of CSCO is up 0.19% at $53.89. JP Morgan upgraded its action to Overweight with a price target of $62, while Exane BNP Paribas downgraded its action to Underperform with a price target of $45.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 4:16 pm

MRVL

A significant bearish stance has been taken on Marvell Tech (NASDAQ:MRVL) by a large investor, as indicated by unusual options trades. The sentiment among these big-money traders is split, with 35% bullish and 64% bearish. The whales have been targeting a price range from $55.0 to $68.0 for Marvell Tech over the last 3 months. The current price of MRVL is up 2.92% at $58.76. Barclays, Wolfe Research, and Stifel have maintained their positive ratings on Marvell Tech with price targets of $75 and $80.

Portfolio Pulse from Benzinga Insights

August 14, 2023 | 4:16 pm

NVDA

NVIDIA shares are trading higher amid strength in the Nasdaq. A Morgan Stanley analyst has also suggested that the recent sell-off in Nvidia stock presents a good entry point for investors.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 4:14 pm

EPIX

Zacks Small-Cap Research has set a $27 price valuation for ESSA Pharma. The company is set to initiate a Phase 2 trial of EPI-7386 in combination with Enzalutamide in the third quarter of 2023.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 4:12 pm

MDNA

Oppenheimer analyst Matthew Biegler has maintained an Outperform rating on Medicenna Therapeutics (NASDAQ:MDNA), but lowered the price target from $8 to $3.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 4:12 pm

CWCO

Janney Montgomery Scott has upgraded Consolidated Water's stock from Neutral to Buy, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 4:09 pm

EHTH

RBC Capital analyst Ben Hendrix has reiterated a 'Sector Perform' rating on eHealth (NASDAQ:EHTH) and maintained a $13 price target.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 4:06 pm

TWO

RBC Capital analyst Kenneth Lee maintains a 'Sector Perform' rating on Two Harbors Inv (NYSE:TWO) and raises the price target from $14 to $15.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 4:04 pm

ROL

RBC Capital analyst Ashish Sabadra has reiterated an Outperform rating on Rollins (NYSE:ROL) and maintained a $52 price target.

Portfolio Pulse from richadhand@benzinga.com

August 14, 2023 | 4:02 pm